Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Thanyanan Chaowanachan"'
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e61416 (2013)
The use of drug combinations has revolutionized the treatment of HIV but there is no equivalent combination product that exists for prevention, particularly for topical HIV prevention. Strategies to combine chemically incompatible agents may facilita
Externí odkaz:
https://doaj.org/article/cbed63ce1e434f27bf87a8a51c66b2ed
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e49792 (2012)
Multipurpose prevention technologies (MPTs) that simultaneously prevent sexually transmitted infections (STIs) and unintended pregnancy are a global health priority. Combining chemical and physical barriers offers the greatest potential to design eff
Externí odkaz:
https://doaj.org/article/ed26f89319814629b60d387a24e96dc3
Autor:
Denise J. Jamieson, Natapakwa Skunodom, Thanyanan Chaowanachan, Anuvat Roongpisuthipong, William A. Bower, Tawee Chotpitayasunondh, Wendy Bhanich Supapol, Wendi L. Kuhnert, Wimol Siriwasin, Jeffrey Wiener, Sanay Chearskul, Michelle S. McConnell, Nathan Shaffer
Publikováno v:
Infectious Diseases in Obstetrics and Gynecology, Vol 2008 (2008)
Objective. The purpose of this study was to describe the epidemiology of coinfection with hepatitis C virus (HCV) and HIV among a cohort of pregnant Thai women. Methods. Samples from 1771 pregnant women enrolled in three vertical transmission of HIV
Externí odkaz:
https://doaj.org/article/0b8b81c321c748359ad883462e2071c5
Autor:
Peter H. Kilmarx, John R. Papp, Frits van Griensven, Lauri E. Markowitz, Sara J. Whitehead, Supaporn Jeeyapant, Wat Uthaivoravit, Thanyanan Chaowanachan, Jordan W. Tappero, Supaporn Chaikummao, Wanna Leelawiwat
Publikováno v:
Sexually Transmitted Diseases. 35:883-888
Monitoring changes in adolescent sexual risk behaviors and sexually transmitted infections is critical for evaluating the effectiveness of human immunodeficiency virus and other prevention programs, but population-based data on adolescents in Thailan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98e8d64ad07eccdf90def81f58cf2bfd
https://doi.org/10.1097/olq.0b013e31817bbc9a
https://doi.org/10.1097/olq.0b013e31817bbc9a
Autor:
Paisit Witwatwongwana, Nucharee Srivirojana, Supaporn Chaikummao, Jordan W. Tappero, Somsak Supawitkul, Kelly Blanchard, Peter H. Kilmarx, Barbara Friedland, Thanyanan Chaowanachan, Philip A. Mock, Cathy Connolly
Publikováno v:
Sexually Transmitted Diseases. 35:226-232
The objectives were to determine the safety and acceptability of use of Carraguard a carrageenan-derived candidate microbicide gel during sexual intercourse in women and men. We conducted a 6-month randomized placebo-controlled trial among sexually a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b244eb22f84ec399b64dc574e5cbae4
https://doi.org/10.1097/olq.0b013e31815d6e0d
https://doi.org/10.1097/olq.0b013e31815d6e0d
Autor:
Liesbeth J. M. Bollen, Anuvat Roongpisuthipong, Rutt Chuachoowong, Suvanna Asavapiriyanont, Thanyanan Chaowanachan, Philip A. Mock, Natapakwa Skunodom, Bongkoch Jetswang, Kanchana Neeyapun, Thomas C. Wright, Mary Culnane, Jordan W. Tappero, Peter H. Kilmarx
Publikováno v:
Sexually Transmitted Diseases. 33:259-264
Human immunodeficiency virus (HIV)-infected women are at increased risk for developing cervical cancer and for infection with human papillomavirus (HPV). Prophylactic vaccines targeting HPV types 16 and 18 are being evaluated for efficacy among young
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de13bbda27a2cf5d4fc6140217af0d27
https://doi.org/10.1097/01.olq.0000187208.94655.34
https://doi.org/10.1097/01.olq.0000187208.94655.34
Autor:
Jordan W. Tappero, Thanyanan Chaowanachan, Orapin Suksripanich, William C. Levine, Thomas J. Spira, Natthaga Sakulploy, Punneeporn Wasinrapee, Egarit Noulsri, Vallerut Pobkeeree, Sombat Thanprasertsuk, Surada Lerdwana, Kovit Pattanapanyasat
Publikováno v:
Clinical and Vaccine Immunology. 12:1416-1424
The advent of potent antiretroviral therapy in 1996 led to a revolution in the care of patients with human immunodeficiency virus (HIV) infection or AIDS. In countries such as Thailand, where antiretroviral drug therapy is now available due to the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6172b291eb018afcaa33afc387f37412
https://doi.org/10.1128/cdli.12.12.1416-1424.2005
https://doi.org/10.1128/cdli.12.12.1416-1424.2005
Autor:
Dale J. Hu, Frits van Griensven, Thomas W. Hodge, Lily Nguyen, Kachit Choopanya, Timothy D. Mastro, Philip A. Mock, Jordan W. Tappero, Robert Nelson, Suphak Vanichseni, Thanyanan Chaowanachan, Janet M. McNicholl
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 37:1318-1323
The loss of viral control by the host may be due to the evolution of viruses with mutations that limit presentation by human leukocyte antigen (HLA) to cytotoxic T cells. The authors hypothesized that the consequence of such evolution might be that p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef6c042118e569aa13f65a122eb51272
https://doi.org/10.1097/01.qai.0000127059.98621.55
https://doi.org/10.1097/01.qai.0000127059.98621.55
Autor:
Peter H. Kilmarx, Somsak Supawitkul, Timothy D. Mastro, Gabriela Paz-Bailey, Maya R. Sternberg, Thanyanan Chaowanachan, Lauri E. Markowitz, Supaporn Jeeyapant, Frits van Griensven
Publikováno v:
Sexually Transmitted Diseases. 30:320-326
BACKGROUND: Previous studies of sexual behavior and sexually transmitted diseases (STDs) in Thai adolescents may have been limited by participation bias and underreporting of stigmatized behaviors. GOAL: The goal was to increase knowledge about risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41293376f28a3c07b56572dc46eb2c20
https://doi.org/10.1097/00007435-200304000-00009
https://doi.org/10.1097/00007435-200304000-00009
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 4, p e61416 (2013)
PLoS ONE, Vol 8, Iss 4, p e61416 (2013)
Background The use of drug combinations has revolutionized the treatment of HIV but there is no equivalent combination product that exists for prevention, particularly for topical HIV prevention. Strategies to combine chemically incompatible agents m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfc5ff13b623e4645948e8183ab6fa37
http://europepmc.org/articles/PMC3632578
http://europepmc.org/articles/PMC3632578